NEJM (Aug 13, 2020) – Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, and survival after diagnosis improved substantially. Our analysis suggests that a reduction in incidence along with treatment advances — particularly approvals for and use of targeted therapies — is likely to explain the reduction in mortality observed during this period.
“The survival benefit for patients with non-small cell lung cancer treated with targeted therapies has been demonstrated in clinical trials, but this study highlights the impact of these treatments at the population level,” said Nadia Howlader, Ph.D., of NCI’s Division of Cancer Control and Population Sciences, who led the study. “We can now see the impact of advances in lung cancer treatment on survival.”
NPR Up First reports: Facebook is launching a tool to help users register to vote. Kamala Harris’ ethnicity will be important to voters of color. And, Thai students protest the military’s involvement in Thai politics.
It’s been about a month since the Chinese Communist Party forced a national security law on Hong Kong. This new law made it illegal for anyone anywhere in the world to promote democratic reform in the region. Recent arrests of top media and political figures have made it clear that Hong Kong’s relatively free political system is over.
NPR News Now reports: Congress fails to agree on a new stimulus bill, President Trump considers action, and other top news.
Staff Writer Meredith Wadman joins host Sarah Crespi to discuss the
Boomers Daily 